Trial Profile
A randomised trial of Myfortic versus mycophenolate in the treatment of multisystem autoimmune disease
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 16 May 2019
Price :
$35
*
At a glance
- Drugs Mycophenolate sodium (Primary) ; Mycophenolate mofetil
- Indications Systemic lupus erythematosus; Systemic vasculitis
- Focus Adverse reactions; Therapeutic Use
- Acronyms MYFMAD
- 16 May 2019 This trial has been completed in UK as European Clinical Trials Database record.
- 19 Sep 2014 New trial record